Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Veru Inc (VERU)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Veru's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.760 +0.190    +3.41%
31/01 - Closed. Currency in USD ( Disclaimer )
After Hours
5.640
-0.120
-2.083%
19:40:48 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,123,592
  • Bid/Ask: 5.640 / 5.880
  • Day's Range: 5.510 - 5.990
Veru 5.760 +0.190 +3.41%

Veru Inc Company Profile

 
Get an in-depth profile of Veru Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPersonal & Household Products & Services
SectorConsumer Non-Cyclicals
Employees

252

Equity Type

ORD

Veru Inc. is an oncology biopharmaceutical company. The Company is focused on developing medicines for the management of breast and prostate cancers. The Company's FC2 segment consists of its commercial product, FC2. The Pharmaceuticals segment includes activities related to multiple drug products under clinical development and ENTADFI, a treatment for benign prostatic hyperplasia. It has a commercial Sexual Health Division, which includes two products, such as ENTADFI, a treatment for benign prostatic hyperplasia (BPH), and the FC2 Female Condom (Internal Condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.

Contact Information

Top Executives

Name Age Since Title
Mitchell S. Steiner 61 2016 Chairman, President & CEO
Harry Fisch 63 2016 Vice Chairman & Chief Corporate Officer
Mario Eisenberger 72 2016 Independent Director
Xiaoqin Lu 47 2021 Independent Director
Michael L. Rankowitz 64 2018 Independent Director
Grace S. Hyun 51 2020 Independent Director
Andrew Sproule Love 79 2013 Board Observer
David D. Ho 69 2023 Chairman of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VERU Comments

Write your thoughts about Veru Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
solo night
solo night Jan 10, 2023 9:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VERU has the proven that it can find cures..stay positive
solo night
solo night Jan 03, 2023 2:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
with Covid-19 cases on the rise world wide..we need VERU to find a cure..super buy. 👍🤗🍸
Glen Vachovski
Glen Vachovski Dec 01, 2022 10:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So weak
simon Leblanc
simon Leblanc Nov 29, 2022 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Patience.
ABDURRAHMAN YILMAZ
ABDURRAHMAN YILMAZ Nov 14, 2022 2:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If you look at the daily chart, it touched the daily rising trend, most probably this week, we will see $8.50 or above.
Gary Ng
Gary Ng Nov 10, 2022 6:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when will VERU resume trading?
Sameer Sharma
samnit24 Nov 07, 2022 3:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What do you all think?
Daniel Sylvia
Daniel Sylvia Oct 15, 2022 7:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Contine to buy at this price. with a late breaking presentation on Sabizabulin due out next weekwith latest data and the 11/9Advisory Committee meeting and an 80% chance of an EUAthis stock is set to take off.
Sameer Sharma
samnit24 Sep 07, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy buy….may not get this proce again…
Chris Cash
ChrisCash Sep 07, 2022 11:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What brought this drop on?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email